BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27340920)

  • 1. Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers.
    Rane JK; Erb HH; Nappo G; Mann VM; Simms MS; Collins AT; Visakorpi T; Maitland NJ
    Oncotarget; 2016 Aug; 7(32):51965-51980. PubMed ID: 27340920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
    Gong P; Zhang T; He D; Hsieh JT
    Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells.
    Sun D; Layer R; Mueller AC; Cichewicz MA; Negishi M; Paschal BM; Dutta A
    Oncogene; 2014 Mar; 33(11):1448-57. PubMed ID: 23503464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
    Kroon J; Puhr M; Buijs JT; van der Horst G; Hemmer DM; Marijt KA; Hwang MS; Masood M; Grimm S; Storm G; Metselaar JM; Meijer OC; Culig Z; van der Pluijm G
    Endocr Relat Cancer; 2016 Jan; 23(1):35-45. PubMed ID: 26483423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FKBP5 and specific microRNAs via glucocorticoid receptor in the basolateral amygdala involved in the susceptibility to depressive disorder in early adolescent stressed rats.
    Xu J; Wang R; Liu Y; Liu D; Jiang H; Pan F
    J Psychiatr Res; 2017 Dec; 95():102-113. PubMed ID: 28826069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation.
    Sun D; Lee YS; Malhotra A; Kim HK; Matecic M; Evans C; Jensen RV; Moskaluk CA; Dutta A
    Cancer Res; 2011 Feb; 71(4):1313-24. PubMed ID: 21212412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone inhibits GRβ coupled prostate cancer cell proliferation.
    Ligr M; Li Y; Logan SK; Taneja S; Melamed J; Lepor H; Garabedian MJ; Lee P
    J Urol; 2012 Sep; 188(3):981-8. PubMed ID: 22819113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells.
    Mao A; Liu Y; Wang Y; Zhao Q; Zhou X; Sun C; Di C; Si J; Gan L; Zhang H
    Tumour Biol; 2016 Apr; 37(4):4831-40. PubMed ID: 26520443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation.
    Hatano K; Kumar B; Zhang Y; Coulter JB; Hedayati M; Mears B; Ni X; Kudrolli TA; Chowdhury WH; Rodriguez R; DeWeese TL; Lupold SE
    Nucleic Acids Res; 2015 Apr; 43(8):4075-86. PubMed ID: 25845598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition.
    El Bezawy R; Tinelli S; Tortoreto M; Doldi V; Zuco V; Folini M; Stucchi C; Rancati T; Valdagni R; Gandellini P; Zaffaroni N
    J Exp Clin Cancer Res; 2019 Feb; 38(1):51. PubMed ID: 30717752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.
    Feng FY; Zhang Y; Kothari V; Evans JR; Jackson WC; Chen W; Johnson SB; Luczak C; Wang S; Hamstra DA
    Neoplasia; 2016 Apr; 18(4):213-22. PubMed ID: 27108384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
    Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
    BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic bases of prostate tumor cell radioresistance.
    Kutilin D
    Klin Onkol; 2021; 34(3):220-234. PubMed ID: 34362257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation modulation of microRNA in prostate cancer cell lines.
    Josson S; Sung SY; Lao K; Chung LW; Johnstone PA
    Prostate; 2008 Nov; 68(15):1599-606. PubMed ID: 18668526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
    Larne O; Hagman Z; Lilja H; Bjartell A; Edsjö A; Ceder Y
    Carcinogenesis; 2015 Aug; 36(8):858-66. PubMed ID: 25969144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells.
    Yano A; Fujii Y; Iwai A; Kawakami S; Kageyama Y; Kihara K
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6012-7. PubMed ID: 17062674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: mifepristone inhibits GRβ coupled prostate cancer cell proliferation.
    Kapoor S
    J Urol; 2013 May; 189(5):1993-4. PubMed ID: 23201377
    [No Abstract]   [Full Text] [Related]  

  • 20. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
    Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
    Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.